{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:40:11Z","timestamp":1791945611373,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/bjc.2013.130","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T22:46:03Z","timestamp":1365115563000},"page":"1743-1749","source":"Crossref","is-referenced-by-count":43,"title":["Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma"],"prefix":"10.1038","volume":"108","author":[{"given":"R","family":"Mezzapelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Miglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Rena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Paganotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Allegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Antona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Frattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Alabiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Boldorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"BFbjc2013130_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ctrv.2010.11.004","volume":"37","author":"V Agarwal","year":"2011","unstructured":"Agarwal V, Lind M, Cawkwell L (2011) Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand? Cancer Treat Rev 37: 533\u2013542.","journal-title":"Cancer Treat Rev"},{"key":"BFbjc2013130_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1309\/AJCPVAGIUC1AHC3Y","volume":"138","author":"S Allegrini","year":"2012","unstructured":"Allegrini S, Antona J, Mezzapelle R, Miglio U, Paganotti A, Veggiani C, Frattini M, Monga G, Balbo P, Boldorini R (2012) Epidermal growth factor receptor gene analysis with a highly sensitivity molecular assay in routine cytologic specimens of lung adenocarcinoma. Am J Clin Pathol 138: 377\u2013381.","journal-title":"Am J Clin Pathol"},{"key":"BFbjc2013130_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.bcp.2011.07.073","volume":"82","author":"F Barbieri","year":"2011","unstructured":"Barbieri F, Wurth R, Favoni RE, Pattarozzi A, Gatti M, Ratto A, Ferrari A, Bajetto A, Florio T (2011) Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesotelioma cell proliferation: insight into EGFR and ERK1\/2 as antitumor targets. Biochem Pharmacol 82: 1467\u20131477.","journal-title":"Biochem Pharmacol"},{"key":"BFbjc2013130_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1183\/09031936.98.12040972","volume":"12","author":"C Boutin","year":"1998","unstructured":"Boutin C, Schlesser M, Frenay C, Astoul P (1998) Malignant pleural mesothelioma. Eur Respir J 12: 972\u2013981.","journal-title":"Eur Respir J"},{"key":"BFbjc2013130_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/sonc.2002.30227","volume":"29","author":"M Carbone","year":"2002","unstructured":"Carbone M, Kratzke RA, Testa JR (2002) The pathogenesis of mesothelioma. Semin Oncol 29: 2\u201317.","journal-title":"Semin Oncol"},{"key":"BFbjc2013130_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1365-2559.2000.00793.x","volume":"36","author":"CE Comin","year":"2000","unstructured":"Comin CE, Anichini C, Boddi V, Novelli L, Dini S (2000) MIB-1 proliferation index correlates with survival in pleural malignant mesothelioma. Histopathology 36: 26\u201331.","journal-title":"Histopathology"},{"key":"BFbjc2013130_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/ijc.21271","volume":"118","author":"JF Cortese","year":"2006","unstructured":"Cortese JF, Gowda AL, Wali A, Eliason JF, Pass HI, Everson RB (2006) Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma. Int J Cancer 118: 521\u2013522.","journal-title":"Int J Cancer"},{"key":"BFbjc2013130_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","volume":"16","author":"D Curran","year":"1998","unstructured":"Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G (1998) Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience. J Clin Oncol 16: 145\u2013152.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013130_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/bjc.1990.207","volume":"61","author":"H Dazzi","year":"1990","unstructured":"Dazzi H, Hasleton PS, Thatcher N, Wilkes S, Swindell R, Chatterjee AK (1990) Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody. Br J Cancer 61: 924\u2013926.","journal-title":"Br J Cancer"},{"key":"BFbjc2013130_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","volume":"51","author":"A Destro","year":"2006","unstructured":"Destro A, Ceresoli GL, Falleni M, Zucali PA, Morenghi E, Bianchi P, Pellegrini C, Cordani N, Vaira V, Alloisio M, Rizzi A, Bosari S, Roncalli M (2006) EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations. Lung Cancer 51: 207\u2013215.","journal-title":"Lung Cancer"},{"key":"BFbjc2013130_CR11","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1200\/JCO.2008.18.0786","volume":"26","author":"M Di Nicolantonio, Martini","year":"2008","unstructured":"Di Nicolantonio, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A (2008) Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 26: 5705\u20135712.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013130_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.lungcan.2005.08.009","volume":"50","author":"K Endo","year":"2005","unstructured":"Endo K, Konishi A, Sasaki H, Takada M, Tanaka H, Okumura M, Kawahara M, Sugiura H, Kuwabara Y, Fukai I, Matsumura A, Yano M, Kobayashi Y, Mizuno K, Haneda H, Suzuki E, Iuchi K, Fujii Y (2005) Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50: 375\u2013384.","journal-title":"Lung Cancer"},{"key":"BFbjc2013130_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/jclinpath-2011-200631","volume":"65","author":"Y Enomoto","year":"2012","unstructured":"Enomoto Y, Kasai T, Takeda M, Takano M, Morita K, Kadota E, Iizuka N, Maruyama H, Haratake J, Kojima Y, Ikeda N, Inatsugi N, Nonomura A (2012) Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma. J Clin Pathol 65: 522\u2013527.","journal-title":"J Clin Pathol"},{"key":"BFbjc2013130_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1245\/s10434-008-0206-6","volume":"16","author":"JM Foster","year":"2009","unstructured":"Foster JM, Gatalica Z, Lilleberg S, Haynatzki G, Loggie BW (2009) Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal respectability in malignant peritoneal mesothelioma. Ann Surg Oncol 16: 152\u2013158.","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2013130_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1477-7819-8-88","volume":"8","author":"JM Foster","year":"2010","unstructured":"Foster JM, Radhakrishna U, Govindarajan V, Carreau JH, Gatalica Z, Sharma P, Nath SK, Loggie BW (2010) Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma. World J Surg Oncol 8: 88.","journal-title":"World J Surg Oncol"},{"key":"BFbjc2013130_CR16","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","volume":"25","author":"LL Garland","year":"2007","unstructured":"Garland LL, Rankin C, Gandara DR, Rivkin SE, Scott KM, Nagle RB, Klein-Szanto AJ, Testa JR, Altomare DA, Borden EC (2007) Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol 25: 2406\u20132413.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013130_CR17","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/JTO.0b013e3182629903","volume":"7","author":"O Gautschi","year":"2012","unstructured":"Gautschi O, Pauli C, Strobel K, Hirschmann A, Printzen G, Aebi S, Diebold J (2012) A patient with BRAF V600E lung adenocarcinoma responding to Vemurafenib. J Thorac Oncol 7: e23\u2013e24.","journal-title":"J Thorac Oncol"},{"key":"BFbjc2013130_CR18","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","volume":"11","author":"R Govindan","year":"2005","unstructured":"Govindan R, Kratzke RA, Herndon JE, Niehans GA, Vollmer R, Watson D, Green MR, Kindler HL (2005) Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Clin Cancer Res 11: 2300\u20132304.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2013130_CR19","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa071834","volume":"357","author":"DJ Jonker","year":"2007","unstructured":"Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, Berry SR, Krahn M, Price T, Simes RJ, Tebbutt NC, van Hazel G, Wierzbicki R, Langer C, Moore MJ (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357: 2040\u20132048.","journal-title":"N Engl J Med"},{"key":"BFbjc2013130_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3892\/ijo.2012.1607","volume":"41","author":"J Kurai","year":"2012","unstructured":"Kurai J, Chikumi H, Hashimoto K, Takata M, Sako T, Yamaguchi K, Kinoshita N, Watanabe M, Touge H, Makino H, Igishi T, Hamada H, Yano S, Shimizu E (2012) Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma. Int J Oncol 41: 1610\u20131618.","journal-title":"Int J Oncol"},{"key":"BFbjc2013130_CR21","first-page":"718","volume":"34","author":"BP Lanphear","year":"1992","unstructured":"Lanphear BP, Buncher CR (1992) Latent period for malignant mesothelioma of occupational origin. J Occup Med 34: 718\u2013721.","journal-title":"J Occup Med"},{"key":"BFbjc2013130_CR22","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","volume":"66","author":"A Li\u00e8vre","year":"2006","unstructured":"Li\u00e8vre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, C\u00f4t\u00e9 JF, Tomasic G, Penna C, Ducreux M, Rougier P, Penault-Llorca F, Laurent-Puig P (2006) KRAS mutation status is predictive to response to cetuximab therapy in colorectal cancer. Cancer Res 66: 3992\u20133995.","journal-title":"Cancer Res"},{"key":"BFbjc2013130_CR23","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-10-3137","volume":"17","author":"F Molinari","year":"2011","unstructured":"Molinari F, Felicioni L, Buscarino M, De Dosso S, Buttitta F, Malatesta S, Movilia A, Luoni M, Boldorini R, Alabiso O, Girlando S, Soini B, Spitale A, Di Nicolantonio F, Saletti P, Crippa S, Mazzucchelli L, Marchetti A, Bardelli A, Frattini M (2011) Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. Clin Cancer Res 17: 4901\u20134914.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2013130_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649\u2013655.","journal-title":"Am J Clin Oncol"},{"key":"BFbjc2013130_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00432-008-0384-4","volume":"134","author":"K Okuda","year":"2008","unstructured":"Okuda K, Sasaki H, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y (2008) Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma. J Cancer Res Clin Oncol 134: 1105\u20131111.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFbjc2013130_CR26","first-page":"333","volume":"152","author":"JC Pache","year":"1998","unstructured":"Pache JC, Janssen YM, Walsh ES, Quinlan TR, Zanella CL, Low RB, Taatjes DJ, Mossman BT (1998) Increased epidermal growth-factor receptor protein in a human mesothelial cell line in response to long asbestos fibers. Am J Pathol 152: 333\u2013340.","journal-title":"Am J Pathol"},{"key":"BFbjc2013130_CR27","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M (2004) EGFR mutation in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497\u20131500.","journal-title":"Science"},{"key":"BFbjc2013130_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","volume":"79","author":"J Peto","year":"1999","unstructured":"Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79: 666\u2013672.","journal-title":"Br J Cancer"},{"key":"BFbjc2013130_CR29","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1097\/JTO.0b013e3181f1c8de","volume":"5","author":"R Pirker","year":"2011","unstructured":"Pirker R, Herth FJF, Kerr KM, Filipits M, Taron M, Gandara D, Hirsch FR, Grunenwald D, Popper H, Smit E, Dietel M, Marchetti A, Manegold C, Schirmacher P, Thomas M, Rosell R, Cappuzzo F, Stahel R (2011) Consensus of EGFR mutation testing in non-small cell lung cancer: result from a European workshop. J Thorac Oncol 5: 1706\u20131713.","journal-title":"J Thorac Oncol"},{"key":"BFbjc2013130_CR30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jso.21901","volume":"104","author":"O Rena","year":"2011","unstructured":"Rena O, Boldorini LR, Gaudino E, Casadio C (2011) Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations. J Surg Oncol 104: 701\u2013705.","journal-title":"J Surg Oncol"},{"key":"BFbjc2013130_CR31","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/0008-5472.CAN-08-2466","volume":"69","author":"A Sartore-Bianchi","year":"2009","unstructured":"Sartore-Bianchi A, Martini M, Molinari F, Veronese S, Nichelatti M, Artale S, Di Nicolantonio F, Saletti P, De Dosso S, Mazzucchelli L, Frattini M, Siena S, Bardelli A (2009) PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. Cancer Res 69: 1851\u20131857.","journal-title":"Cancer Res"},{"key":"BFbjc2013130_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa050753","volume":"353","author":"FA Shepherd","year":"2005","unstructured":"Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, van Kooten M, Dediu M, Findlay B, Tu D, Johnston D, Bezjak A, Clark G, Santab\u00e1rbara P, Seymour L (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353: 123\u2013132.","journal-title":"N Engl J Med"},{"key":"BFbjc2013130_CR33","first-page":"142","volume-title":"TNM Classification of Malignant Tumours","author":"LH Sobin","year":"2009","unstructured":"Sobin LH, Gospodarowic MK, Wittekind (2009) TNM Classification of Malignant Tumours 7th edn. pp 142\u2013145. Wiley-Blackwell: Oxford, UK."},{"key":"BFbjc2013130_CR34","first-page":"181","volume":"2","author":"Y Suzuki","year":"2009","unstructured":"Suzuki Y, Murakami H, Kawaguchi K, Tanigushi T, Fujii M, Shinjo K, Kondo Y, Osada H, Shimokata K, Horio Y, Hasegawa Y, Hida T, Sekido Y (2009) Activation of the PI3K-AKT pathway in human malignant mesothelioma cells. Mol Med Report 2: 181\u2013188.","journal-title":"Mol Med Report"},{"key":"BFbjc2013130_CR35","first-page":"125","volume-title":"World Health Organization Classification of tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"WD Travis","year":"2004","unstructured":"Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC (2004) World Health Organization Classification of tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart pp 125\u2013136. IARC Press: Lyon, France."},{"key":"BFbjc2013130_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/JTO.0b013e31819c8661","volume":"4","author":"V Velcheti","year":"2009","unstructured":"Velcheti V, Kasai Y, Viswanathan AK, Ritter J, Govindan R (2009) Absence of mutations in the epidermal growth factor receptor (EGFR) kinase domain in patients with mesothelioma. J Thorac Oncol 4: 559.","journal-title":"J Thorac Oncol"},{"key":"BFbjc2013130_CR37","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21: 2636\u20132644.","journal-title":"J Clin Oncol"},{"key":"BFbjc2013130_CR38","first-page":"260","volume":"17","author":"JC Wagner","year":"1960","unstructured":"Wagner JC, Sleggs P, Marchand P (1960) Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17: 260\u2013271.","journal-title":"Br J Ind Med"},{"key":"BFbjc2013130_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","volume":"9","author":"H Yang","year":"2008","unstructured":"Yang H, Testa JR, Carbone M (2008) Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Opt Oncol 9: 147\u2013157.","journal-title":"Curr Treat Opt Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2013130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013130","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:13:39Z","timestamp":1684415619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2013130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFbjc2013130"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.130","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}